Cargando…
The NLRP3 Genetic Variant (rs10754555) Reduces the Risk of Adverse Outcome in Middle-Aged Patients with Chronic Coronary Syndrome
BACKGROUND: Inflammation is central in development of cardiovascular disease (CVD). Aberrant function of the Nod-Like Receptor Protein 3 (NLRP3) inflammasome, a central mediator in the proinflammatory response, has been associated with atherosclerosis. The influence of genetic determinants on this i...
Autores principales: | Opstad, Trine B., Nordeng, Jostein, Pettersen, Alf-Aage R., Åkra, Sissel, Bratseth, Vibeke, Zaidi, Hani, Helseth, Ragnhild, Solheim, Svein, Seljeflot, Ingebjørg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794420/ https://www.ncbi.nlm.nih.gov/pubmed/36582742 http://dx.doi.org/10.1155/2022/2366695 |
Ejemplares similares
-
Circulating Microvesicles in Association with the NLRP3 Inflammasome in Coronary Thrombi from STEMI Patients
por: Bratseth, Vibeke, et al.
Publicado: (2022) -
The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery
por: Åkra, Sissel, et al.
Publicado: (2022) -
Gene expression of fibrinolytic markers in coronary thrombi
por: Nordeng, Jostein, et al.
Publicado: (2022) -
The Inflammasome Signaling Pathway Is Actively Regulated and Related to Myocardial Damage in Coronary Thrombi from Patients with STEMI
por: Nordeng, Jostein, et al.
Publicado: (2021) -
Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment
por: Bratseth, Vibeke, et al.
Publicado: (2012)